0.00–0.34
Low
Continue the screening schedule recommended by your doctor.
Loading page
SeroMark-1 uses advanced serum phospholipid profiling combined with predictive analytics to estimate the likelihood of prostate cancer and support an informed clinical conversation.
Screening aid only · Not a diagnosis · Doctor interpretation required
Controlled preparation. Quality checks. Structured clinical context.
SeroMark-1 is designed to add molecular information to the established prostate cancer assessment pathway—not to replace the wider clinical evaluation.
SeroMark-1 may be considered when one or more of these statements applies. Final suitability should be confirmed through an appropriate healthcare professional.
The index is not interpreted alone. Your doctor considers it alongside your age, medical history, examination findings, and other appropriate tests.
0.00–0.34
Continue the screening schedule recommended by your doctor.
0.35–0.49
Discuss the result and relevant clinical context with your doctor.
0.50–1.00
Prompt clinical review may be recommended to determine appropriate next steps.
A band does not confirm or exclude cancer. Never delay medical care because of an online explanation or a screening result.
Clear answers help patients and families make better-informed decisions with their healthcare professionals.
View every questionNo. SeroMark-1 is a screening aid that provides additional risk information. Diagnosis requires doctor-led clinical evaluation and, where appropriate, further investigation.
No. The screening pathway is designed for proactive risk assessment, including men who feel well. A doctor should still confirm whether testing is suitable for you.
No. SeroMark-1 is intended to complement established clinical information. Your doctor may use PSA, examination findings, imaging, family history, and other evidence when deciding what happens next.
Results are presented as a structured risk index and should be reviewed with a qualified healthcare professional through the available clinical channel.
See how the sample moves from collection to clinical review, or search for access in your city.